|
Re: BOM 2 Trial
|
5
|
Resverlogix Corp.
|
Jun 10, 2020 12:12PM
|
|
Presentation available
|
2
|
Resverlogix Corp.
|
Jun 10, 2020 10:47AM
|
|
Re: Random thoughts RVX-208 and COVID-19
|
6
|
Resverlogix Corp.
|
Apr 12, 2020 09:47PM
|
|
Re: DM Interview w Jane King (Innovators) Apr 7 - COVID 19
|
12
|
Resverlogix Corp.
|
Apr 09, 2020 12:11AM
|
|
Re: RAAS Inhibitors in Patients with Covid-19
|
4
|
Resverlogix Corp.
|
Mar 31, 2020 10:58AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 26, 2020 02:55PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
8
|
Resverlogix Corp.
|
Mar 26, 2020 02:36PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
9
|
Resverlogix Corp.
|
Mar 26, 2020 01:10PM
|
|
SARS-CoV-2 and BRD interactions
|
6
|
Resverlogix Corp.
|
Mar 24, 2020 05:56PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
4
|
Resverlogix Corp.
|
Mar 24, 2020 05:00PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
5
|
Resverlogix Corp.
|
Mar 24, 2020 04:33PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
2
|
Resverlogix Corp.
|
Mar 24, 2020 04:20PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 24, 2020 03:54PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
8
|
Resverlogix Corp.
|
Mar 24, 2020 02:05PM
|
|
Re: Angiotensin and Coronavirus
|
3
|
Resverlogix Corp.
|
Mar 23, 2020 10:20PM
|
|
Re: Epigenetics and Coronavirus
|
8
|
Resverlogix Corp.
|
Mar 23, 2020 05:14PM
|
|
Re: Epigenetics and Coronavirus
|
5
|
Resverlogix Corp.
|
Mar 23, 2020 04:22PM
|
|
Re: BD2 specific inhibitors mentioned in Science
|
4
|
Resverlogix Corp.
|
Mar 22, 2020 01:46PM
|
|
Re: Dear Dr. Shokat -- Received a reply !!
|
7
|
Resverlogix Corp.
|
Mar 18, 2020 04:07PM
|
|
Re: Dear Dr. Shokat -- Received a reply !!
|
7
|
Resverlogix Corp.
|
Mar 18, 2020 03:54PM
|
